Increased antibiotic resistance is leading pharmaceutical companies to shift their focus back to penicillin, a once heavily relied upon antibiotic. A resurgence in penicillin research, coupled with technological advancements in biotech, has been driving growth in this segment. However, the market faces challenges relating to stringent regulatory compliance and high...
Discover more insightsThe global antibiotic market is experiencing rapid change, largely driven by increasing drug resistance and a heightened demand for novel treatments. Despite the considerable efforts made by pharmaceutical companies, the rate of novel antibiotic development lags behind the growing issue of antibiotic resistance, making this a highly dynamic and urgent...
Discover more insightsResistant Pseudomonas aeruginosa, an opportunistic pathogen impacting immunocompromised individuals, is a matter of global concern. The ability of this bacteria to garner resistance towards conventional antibiotics poses a serious challenge to healthcare systems. Traditional therapies tend to lose efficacy over time as drug-resistance cultivates. This has driven the scientific community...
Discover more insightsSignificant advancements have recently been made within the realm of clinical trials focused on combating Methicillin-Resistant Staphylococcus Aureus (MRSA) infections. These studies have commenced the groundwork on understanding intricacies of MRSA, thus posing affirmation on treatment opportunities. Moreover, the trials extensive nature has emphasized the ongoing advancement in understanding how...
Discover more insightsIn the pharmaceutical segment that targets VRSA infections, a condition of growing global alarm due to antibiotic resistance, the situation remains challenging. Despite a significant requirement for effective medications, the development pipeline seems stunted, largely owing to the high costs of R&D, combined with the difficulty of developing drugs faster...
Discover more insightsAntibiotic-resistant bacteria are posing a worldwide health threat, with Staphylococcus Aureus among the most commonly encountered species. Innovations in treatment strategies are beginning to swing the tide. A rise in the development of bacteriophage therapy, the use of viruses that infect bacteria, is being seen. Biopharmaceutical companies are also developing...
Discover more insightsIn recent years, Antimicrobial Susceptibility Testing (AST) has emerged as a key tool in animal healthcare systems. This could be attributed to heightened awareness around antimicrobial resistance, which poses significant risks to both animal and human health. Given that AST helps understand the efficacy of antimicrobials on specific microorganisms, its...
Discover more insightsThe ongoing battle against infectious diseases has driven significant progress in medical technologies. Among these, antimicrobial susceptibility testing (AST) methods have undergone substantial evolution. Initially, AST focused on single bacterial pathogens, using processes like disk diffusion, broth dilution, or automated methods. As understanding of microbial behaviour and resistance has advanced,...
Discover more insightsRapid technological advancements have catalyzed the research and development (R&D) aspect of the anti-MRSA drugs industry, making discovery and formulation of new and effective drugs a reality. Broader accessibility to personalised healthcare and the growing prevalence of hospital-acquired MRSA infections are notable factors driving market growth. Conversely, challenges are, however,...
Discover more insightsExpansion in the penicillin drug market is primarily being driven by increasing bacterial resistance to current antibiotic treatments and rising prevalence of infectious diseases worldwide. Further factors include advancements in pharmaceutical research and innovation, which are refining the effectiveness of these drugs and expanding their potential applications. In addition, policies...
Discover more insightsIdentifying pathogenic threats accurately is of paramount importance in healthcare. Bacterial resistance questioning the efficacy of traditional antibiotics, has made the task formidable. Here is where the antimicrobial susceptibility testing (AST) market comes to play a crucial role. AST allows clinicians to expose bacteria or fungi to diverse drug samples...
Discover more insights